Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · December 24, 2023

Efficacy of Dupilumab in Patients With Eosinophilic Oesophagitis With or Without Prior Use of Swallowed Topical Corticosteroids

Gut

 

Additional Info

Gut
Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study
Gut 2023 Dec 16;[EPub Ahead of Print], AJ Bredenoord, ES Dellon, I Hirano, AJ Lucendo, C Schlag, X Sun, L Glotfelty, L Mannent, J Maloney, E Laws, E Mortensen, A Shabbir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading